Oculis Holding AG (OCS) Form 10-K Annual Reports
Oculis Holding AG (OCS) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: OCS
CIK: 1953530
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: V8
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers AG
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerAlex Fuhrer
Audit LocationLausanne, Switzerland
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-09-30 | 2026-09-30 | 6-K | 0001193125-26-409212 | View SEC Doc Filr Page |
| 6-K | 2026-08-10 | 2026-08-10 | 6-K | 0001193125-26-341298 | View SEC Doc Filr Page |
| S-8 | 2026-08-06 | — | S-8 | 0001193125-26-338315 | View SEC Doc Filr Page |
| 6-K | 2026-08-06 | 2026-06-30 | 6-K | 0001193125-26-338054 | View SEC Doc Filr Page |
| 6-K | 2026-06-25 | 2026-06-25 | 6-K | 0001193125-26-282715 | View SEC Doc Filr Page |
| 6-K | 2026-06-01 | 2026-05-29 | 6-K | 0001193125-26-248946 | View SEC Doc Filr Page |
| 6-K | 2026-05-14 | 2026-05-14 | 6-K | 0001193125-26-223970 | View SEC Doc Filr Page |
| 6-K | 2026-05-11 | 2026-03-31 | 6-K | 0001193125-26-216741 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-04-29 | — | SCHEDULE 13G/A Filing | 0001193125-26-191908 | View SEC Doc Filr Page |
| 6-K | 2026-04-21 | 2026-04-21 | 6-K | 0001193125-26-166790 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-03-27 | — | SCHEDULE 13G/A Filing | 0001104659-26-035543 | View SEC Doc Filr Page |
| 144 | 2026-03-09 | — | 144 Filing | 0001969223-26-000321 | View SEC Doc Filr Page |
| 6-K | 2026-03-04 | 2026-03-04 | 6-K | 0001193125-26-091653 | View SEC Doc Filr Page |
| F-3ASR | 2026-03-04 | — | F-3ASR | 0001193125-26-091561 | View SEC Doc Filr Page |
| 20-F | 2026-03-04 | 2025-12-31 | 20-F | 0001193125-26-091446 | View SEC Doc Filr Page |
| 6-K | 2026-03-03 | 2026-03-03 | 6-K | 0001193125-26-088209 | View SEC Doc Filr Page |
| EFFECT | 2025-12-08 | — | EFFECT Filing | 9999999995-25-003564 | View SEC Doc Filr Page |
| POS AM | 2025-12-05 | — | POS AM | 0001193125-25-309605 | View SEC Doc Filr Page |
| 424B3 | 2025-12-01 | — | 424B3 | 0001193125-25-303918 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-11-14 | — | SCHEDULE 13G/A Filing | 0001012975-25-000770 | View SEC Doc Filr Page |
| F-3 | 2025-11-10 | — | F-3 | 0001193125-25-274458 | View SEC Doc Filr Page |
| 6-K | 2025-11-10 | 2025-11-10 | 6-K | 0001193125-25-274212 | View SEC Doc Filr Page |
| 424B5 | 2025-10-31 | — | 424B5 | 0001193125-25-260991 | View SEC Doc Filr Page |
| 424B5 | 2025-10-31 | — | 424B5 | 0001193125-25-260967 | View SEC Doc Filr Page |
| 6-K | 2025-10-31 | 2025-10-31 | 6-K | 0001193125-25-260916 | View SEC Doc Filr Page |